Kolexia
Kirov Youlia
Radio-thérapie
Clcc Institut Curie
Paris, France
445 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Lymphomes Récidive tumorale locale Métastase tumorale Maladie de Hodgkin Carcinomes Tumeurs du cerveau Cardiotoxicité Carcinome canalaire du sein

Industries

P\S\L Group Services
76 collaboration(s)
Dernière en 2023
B3TSI
22 collaboration(s)
Dernière en 2023
Zeste Research
20 collaboration(s)
Dernière en 2021
IQVIA
16 collaboration(s)
Dernière en 2023

Dernières activités

MEDIRAD-BRACE: Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events (MEDIRAD-BRACE): A Retrospective Cohort Study
Essai Clinique (University Medical Center Groningen)   26 février 2024
RadioPARP: A Phase I of Olaparib With Radiation Therapy in Patients With Inflammatory, Loco-regionally Advanced or Metastatic TNBC (Triple Negative Breast Cancer) or Patient With Operated TNBC With Residual Disease
Essai Clinique (AstraZeneca)   29 janvier 2024
Management of second ipsilateral breast tumor event: An advocacy for a randomized trial.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   11 janvier 2024
Primary ophthalmic natural killer/T-cell lymphoma: A population-based study.
Bulletin du cancer   09 janvier 2024
Post-mastectomy reirradiation for ipsilateral T3N0M0 breast tumor relapse: a population-based study.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]   02 janvier 2024
Evolution of radiotherapy techniques for mediastinal Hodgkin lymphoma: a single-center experience.
Mediastinum (Hong Kong, China)   07 décembre 2023
Radiation therapy of the primary tumour and oligometastatic sites in patients with breast cancer with synchronous metastases: A literature review.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   07 décembre 2023
Rare tumours of the breast.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   02 novembre 2023
Impact of Brentuximab Vedotin in Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma with Capsule Infiltration Requiring Chemotherapy
65th ASH Annual Meeting Abstracts   02 novembre 2023
Tolerance of concurrent adjuvant radiotherapy and pembrolizumab for triple negative breast cancer: real life experience
Advances in radiation oncology   17 octobre 2023